BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG
BDR Pharma on Monday stated it has inked a licensing % with the Defence Research and Development Organisation (DRDO) to fabricate, distribute, and marketplace COVID-19 drug 2-Deoxy-D-Glucose (2-DG) withinside the…
